Clinical trials recruiting for Rheumatoid arthritis
314
Recruiting trials
45
US states with sites
60
Countries
12%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Methotrexate | 10 |
| Fludarabine | 5 |
| Rituximab | 5 |
| Cyclophosphamide | 4 |
| Etanercept | 4 |
| Tofacitinib | 4 |
| Hydroxychloroquine | 3 |
| Leflunomide | 3 |
| YTS109 cell | 3 |
| Abatacept | 2 |
| Adalimumab | 2 |
| Afimkibart | 2 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 30 |
| Florida | 30 |
| Texas | 28 |
| North Carolina | 20 |
| Illinois | 19 |
| New York | 19 |
| Pennsylvania | 17 |
| Colorado | 16 |
| Arizona | 15 |
| Michigan | 15 |
| Massachusetts | 12 |
| Alabama | 10 |
Top cities
Houston, Texas 17New York, New York 12Boston, Massachusetts 11Chicago, Illinois 11Aurora, Colorado 9Charlotte, North Carolina 9Clearwater, Florida 9Duncansville, Pennsylvania 9Durham, North Carolina 9Miami, Florida 9
Self-screener
Recruiting trials
- "Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"
- "Translating Articular Biomarkers Into Diagnoses"
- 7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis
- A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
- A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
- A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
- A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
- A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
- A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA).
- A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)
- A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
- A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
- A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
- A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
- A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
- A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
- A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
- A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
- A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS.
- A RWS of SC MTX in Chinese RA Patients
- A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
- A Study With CIT-013 in RA Patients
- A Study of AZD0120 in Autoimmune Diseases
- A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
- A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis
- A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
- A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
- A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
- A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease
- A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
- A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
- A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis
- A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
- A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
- A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- AYLo - AutoimmunitY and Loss of y
- Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
- Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
- Advanced Therapeutics in Rheumatoid Arthritis (RA)
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- An Alternative Assessment in Patients with Rheumatoid Arthritis: 6 Minute Step Test
- An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
- An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
- An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- An Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis
- An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS
- An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
- Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
- Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
- Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
- Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
- Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
- Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.
- At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]
- Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
- Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
- B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
- Belimumab After Rituximab in Resistant Primary Juvenile SS
- Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
- Biobank for Inflammatory Chronic Diseases and Osteoporosis
- Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
- BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote Monitoring in Rheumatoid Arthritis
- CAR-T Cells Therapy for Patients With Autoimmune Diseases
- COMFI - a COMbined Fatigue Intervention
- COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
- Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
- Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)
- Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
- Characterization of Diseases With Salivary Gland Involvement
- Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
- Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
- Clinical Outcomes Study of the Nexel Total Elbow
- Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis
- Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
- Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide
Related conditions
Trials recruiting for Rheumatoid arthritis often also study these conditions. Each links to its own recruiting-trial list.
Lupus 332Psoriasis 233Systemic lupus erythematosus 119Sjogren's Syndrome 25Osteoarthritis 611Arthritis, Rheumatoid 17Systemic Sclerosis (SSc) 28Systemic Sclerosis 27Autoimmune Diseases 29Psoriatic arthritis 45
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Rheumatoid arthritis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.